Yumanity Therapeutics Announces Definitive Agreements for
Yumanity Therapeutics, Inc. to sell its clinical-stage product candidate YTX-7739 as well as its unpartnered discovery-stage neuroscience product...
Source: globenewswire.com
Growth Value Development Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Growth Value Development Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Growth Value Development Inc Today - Breaking & Trending Today
Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premium
Proceeds expected to support Exicure’s continued advancement of preclinical candidates including its SCN9A product candidate, a non-opioid pain analgesicThe private placement is being led by a subsidiary of CBI Co., Ltd. (“CBI”), a member of a leading investment group in South Korea focusing on science-based compani...
Source: pharmiweb.com